Description

EMTRICITABINE+TENOFOVIR DISOPROXIL belongs to a group of antiretroviral medicines used to treat HIV infection. EMTRICITABINE+TENOFOVIR DISOPROXIL helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illness such as cancer or serious infections. EMTRICITABINE+TENOFOVIR DISOPROXIL also helps in reducing the risk of getting HIV-1 infection when used as a daily treatment along with practising safe sex.

 

EMTRICITABINE+TENOFOVIR DISOPROXIL is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. EMTRICITABINE+TENOFOVIR DISOPROXIL works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, EMTRICITABINE+TENOFOVIR DISOPROXIL helps in treating HIV infection.

 

You are advised to take EMTRICITABINE+TENOFOVIR DISOPROXIL for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, EMTRICITABINE+TENOFOVIR DISOPROXIL may cause certain common side-effects such as headache, dizziness, nausea, vomiting, diarrhoea, weakness, and rash. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.

 

Practise safe sex and take necessary precautions, as EMTRICITABINE+TENOFOVIR DISOPROXIL does not prevent the spread of HIV infection. Consult your doctor if you are pregnant or planning for pregnancy. Avoid breastfeeding while taking EMTRICITABINE+TENOFOVIR DISOPROXIL. EMTRICITABINE+TENOFOVIR DISOPROXIL may cause dizziness, so drive with caution. EMTRICITABINE+TENOFOVIR DISOPROXIL is not recommended for children below 12 years. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side-effects/interactions.

Uses of EMTRICITABINE+TENOFOVIR DISOPROXIL

HIV infection

Medicinal Benefits

EMTRICITABINE+TENOFOVIR DISOPROXIL belongs to a group of antiretroviral medicines used to treat HIV infection. EMTRICITABINE+TENOFOVIR DISOPROXIL helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illnesses such as cancer or serious infections. EMTRICITABINE+TENOFOVIR DISOPROXIL is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. EMTRICITABINE+TENOFOVIR DISOPROXIL works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, EMTRICITABINE+TENOFOVIR DISOPROXIL helps in treating HIV infection. Taking EMTRICITABINE+TENOFOVIR DISOPROXIL along with practising safe sex and lifestyle changes may reduce the risk of getting or transmitting the HIV virus to others. 

Directions for Use

Take EMTRICITABINE+TENOFOVIR DISOPROXIL with food. Swallow EMTRICITABINE+TENOFOVIR DISOPROXIL as a whole with water; do not chew or crush it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of EMTRICITABINE+TENOFOVIR DISOPROXIL

• Headache
• Dizziness
• Nausea
• Vomiting
• Diarrhoea
• Weakness
• Rash